• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

apebay@unimelb.edu.au

Credentials


Position
Principal Research Fellow
Department of Surgery
Education

Universite Vincennes-Saint-Denis (Paris VIII)
PhD
Universite Pierre et Marie Curie (Paris VI)

Universite Pierre et Marie Curie (Paris VI)

Universite Louis Pasteur (Strasbourg I)
ORCID

0000-0002-7408-9453

Prof Alice Pebay

Principal Research Fellow
Department of Surgery

197 Scholarly works
41 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration
    DOI: 10.1186/s13073-026-01658-2
  • 2026

    Journal article

    Human pluripotent stem cell-derived retinal ganglion cells: advances in differentiation and translational applications
    DOI: 10.1186/s10020-025-01405-0
  • 2026

    Journal article

    Single-cell analysis reveals cellular heterogeneity and limits of marker-based assessment in retinal ganglion cell-enriched organoid cultures
    DOI: 10.1186/s10020-026-01488-3
  • 2026

    Journal article

    Biofabrication of Hierarchical Medium-Sized Branched Blood Vessel Scaffolds Utilising Negative Embodied Sacrificial Template 3D and Human-Induced Pluripotent Stem Cells.
    DOI: 10.1021/acsbiomaterials.6c00197
  • 2020

    Research Grant

    A Pathway to Translation: Uncovering Novel Causes, Genetic Associations and Potential Intervention Strategies for Age Related Macular Degeneration
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    A Pathway to Translation: Uncovering Novel Causes, Genetic Associations and Potential Intervention Strategies for Age Related Macular Degeneration
  • 2018

    Research Grant

    Novel Mechanisms of Early Age Related Macular Degeneration
Alice Pebay

Latest Honours,
Awards and Fellowships


2023

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Frataxin deficiency drives cardiac dysfunction and transcriptional dysregulation in Friedreich ataxia iPSC model.
    DOI: 10.1038/s41419-026-09030-3
  • 2026

    Journal article

    Retraction notice to “Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying thePSEN1 H163Rmutation” [Stem Cell Res. 79 (2024) 103495]
    DOI: 10.1016/j.scr.2026.103956
  • 2026

    Journal article

    Australasian consensus recommendations on stem cell therapies for managing ocular surface diseases
    DOI: 10.1016/j.jtos.2026.02.004
  • 2026

    Journal article

    Advancing a novel ASO therapy for Friedreich ataxia cardiomyopathy using a pre-clinical human vascularised cardiac organoid model
    DOI: 10.1016/j.jmccpl.2025.100527
  • 2026

    Book Chapter

    Quantification of Drusen-Like Deposits in Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cells Using Confocal Microscopy
    DOI: 10.1007/978-1-0716-5198-8_5
  • 2026

    Journal article

    Deep Learning-Based Detection of Reticular Pseudodrusen in Age-Related Macular Degeneration
    DOI: 10.1111/ceo.14607

RECENT PROJECTS

  • 2024

    Research grants (ARC, NHMRC, MRFF)

    POPSTEM: Patient-Specific Cardiac Stem Cell Villages for Personalised Therapeutic Design
  • 2025

    Research grants (other domestic)

    Stem Cell Disease Modelling

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224